Strota/ Newsroom/ 2026-07-20

RUBICON (RUBICON): Acquisition / M&A

Strota Newsroom · session of 2026-07-20 · 20 Jul 17:34 · RUBICON stock page →

Rubicon Research Limited has informed the Exchange regarding Outcome of Board Meeting held on July 20, 2026.1. Date of 2… Historically, acquisition / m&a events have moved RUBICON-type stocks in the bullish direction 48.9% of the next sessions (n=141).

Rubicon Research informed the exchange on July 20, 2026 that its board discussed the merger of Kia Health Tech Private Limited, a wholly-owned subsidiary, with the company itself, according to the NSE filing. The disclosure also noted the date for the 27th Annual General Meeting and the record date for final dividend payment for FY2025-26.

Events like this—acquisitions or mergers—have historically shown a 48.9% win rate across 141 comparable instances, with a net edge of 0.213%, according to Strota's base rate data for this catalyst type. This means slightly under half of similar events have produced positive outcomes historically, though the sample offers no guarantee for any individual stock.

The stock trades at a price-to-earnings multiple of 99.07 and a price-to-book ratio of 19.33, with a market capitalisation of ₹24,907 crore and return on equity of 27.0%. Earnings per share stand at ₹15.26. The Nifty 50 declined 0.39% on the session.

The filing confirms board-level discussion of the merger and dividend timing, but does not disclose deal terms, completion timeline, or financial impact. The historical base rate describes past patterns for this event category, not a forecast for Rubicon Research specifically.

The catalyst

Rubicon Research Limited has informed the Exchange regarding Outcome of Board Meeting held on July 20, 2026.1. Date of 27th Annual General Meeting and Record Date for payment of final dividend on equity shares for the financial year 2025-26.2. Update on the merger of Kia Health Tech Private Limited, WOS, with Rubicon Research Limited (filing · NSE)

What the data shows after this event

Across Strota's backtest of past filings, Acquisition / M&A shows no reliable next-session edge — the move went bullish in about 48.9% of next sessions (net 0.213% after drift and cost, n=141). A base rate, not a forecast for this stock.

RUBICON right now

P/E 99.07. Full RUBICON analysis →

Sources

Keep digging

How this article was made: Strota assembled the exchange data above (prices, F&O open interest, bulk/block deals, SEBI PIT filings, indicator readings and public headlines) and an AI model wrote the narrative strictly from that evidence — it is not permitted to add outside facts or numbers. Every figure comes from the underlying exchange/public data.